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Abstract
Background: A number of gene-profiling methodologies have been applied to microRNA research. The diversity of the
platforms and analytical methods makes the comparison and integration of cross-platform microRNA profiling data
challenging. In this study, we systematically analyze three representative microRNA profiling platforms: Locked Nucleic Acid
(LNA) microarray, beads array, and TaqMan quantitative real-time PCR Low Density Array (TLDA).
Methodology/Principal Findings: The microRNA profiles of 40 human osteosarcoma xenograft samples were generated by
LNA array, beads array, and TLDA. Results show that each of the three platforms perform similarly regarding intra-platform
reproducibility or reproducibility of data within one platform while LNA array and TLDA had the best inter-platform
reproducibility or reproducibility of data across platforms. The endogenous controls/probes contained in each platform
have been observed for their stability under different treatments/environments; those included in TLDA have the best
performance with minimal coefficients of variation. Importantly, we identify that the proper selection of normalization
methods is critical for improving the inter-platform reproducibility, which is evidenced by the application of two non-linear
normalization methods (loess and quantile) that substantially elevated the sensitivity and specificity of the statistical data
assessment.
Conclusions: Each platform is relatively stable in terms of its own microRNA profiling intra-reproducibility; however, the
inter-platform reproducibility among different platforms is low. More microRNA specific normalization methods are in
demand for cross-platform microRNA microarray data integration and comparison, which will improve the reproducibility
and consistency between platforms.
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Introduction
MicroRNAs (miRNA) are a set of small, single-stranded, non-
coding RNA molecules that bind the complementary 39-UTR
sequence of their target mRNA, preventing translation and
inducing mRNA degradation [1,2]. In this manner, miRNAs are
predicted to regulate the expression of more than 30% of all
human genes and are known to play a key role in many biological
processes, including development, cell growth, differentiation,
apoptosis, and tumorigenesis [3,4,5,6,7,8,9]. Recent studies have
demonstrated the value of miRNA expression patterns for
diagnostic, prognostic, and therapeutic uses [10,11], thus height-
ening interest in miRNAs’ potential as biomarkers for tumor
development, progression, and chemosensitivity. Many well-
established molecular and biological methodologies including
microarray, cloning, northern blotting, quantitative real-time-
PCR (qRT-PCR), in situ hybridization (ISH), and next generation
sequencing (NGS) are now being successfully utilized for miRNA
research [12,13,14,15,16,17]. However, some unique signatures of
miRNAs, such as their small total number and short length, have
created technical obstacles for direct application in various array
platforms, leading to a need for developing novel methodologies
designed to measure miRNA expression with high specificity and
sensitivity. Here, we will systematically compare three represen-
tative platforms that use different carriers: glass slide LNA
microarray, beads-based array, and TLDA quantitative real-time
PCR array. Each has been broadly applied to miRNA profiling.
Microarray technology has been successfully applied in the field
of genomic and biological research over the past decade, allowing
for the simultaneous profiling of tens of thousands of genes
[12,18]. Briefly, cyanine dye-labeled cRNA/cDNA is hybridized
to its complementary detection probe on an array carrier (e.g.
glass, silicon or nylon) and emits fluorescence in the presence of a
laser. The intensity of fluorescence, as caught and measured using
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abundance of bound genes. However, miRNA is much shorter
than mRNA, which provides an important caveat for its use in
classically mRNA-favored technologies. Since mature miRNA
contains only 19-25 nucleotides and detective probes on the array
carrier require the complementary pairing of at least ,20 base
pairs, the full-length sequence of each mature miRNA must
inherently be included in the probes. The effect is a wide Tm
range for the entire miRNA population, resulting in decreased
binding efficacy or fluorescent distortion. The application of
Locked Nucleic Acid (LNA)-modified oligonucleotide probes has
overcome this obstacle by modifying the LNA contents in the
probe, eliminating the diversity of Tm values for individual
miRNA probes by enhancing binding affinity and by leading to
the improvement of miRNA detection specificity and sensitivity
[19]. LNA array is one of multiple successful examples of
microarray technology adopted into miRNA study. Thus, we
selected it to represent microarray technology in our analysis.
Bead-based hybridization carries an expectation of increased
specificity over glass-based microarray [20]. Five-micron polysty-
rene beads, uniquely colored (up to 100 colors) and covered with
oligonucleotide capture probes specific for a single miRNA, are
hybridized to biotinylated miRNA in the liquid phase and then
they are stained with streptavidin-phycoerythrin. A flow cytometer
(Luminex 200) directs a single column of beads through the path of
two lasers; one laser is used to identify the particular miRNA by its
bead color, and the other is used to detect bound quantities of
miRNA based on the presence of the reporter molecule,
phycoerythrin. Bead-based arrays allow for the inclusion of many
combinations of miRNA capture beads into a single pool, which
are adjusted based on the interaction of bead-coupled probes, and
provides greater flexibility over time as miRNA are discovered and
corresponding beads are created. Indeed, beads-based miRNA
detection is both feasible and attractive for its high speed,
heightened accuracy, and relatively low cost [20].
Quantitative real-time RT-PCR (qRT-PCR) assay is a rapid
and reproducible methodology with a broad dynamic range
compared to Northern blot or conventional RT-PCR when
assessing RNA expression [21]. It has been widely applied in
miRNA research for years and recognized therein as a gold
standard [22]. TaqMan is a relatively mature technology for the
qRT-PCR application and has been adopted into miRNA
research utilizing a stem-loop structure specific for binding mature
miRNA [15]. The development of TaqMan technology has led to
an innovative design of Low Density Arrays (TLDA), a medium-
throughput method for real-time RT-PCR that uses 384-well
microfluidics cards. A single TLDA card may assay up to 384
miRNAs. In theory, this technology provides a feasible platform
combining miRNA discovery and validation.
In this study, we will profile miRNAs from a panel of
osteosarcoma xenografts using LNA microarray, beads array,
and TLDA, respectively. Systematic comparison and evaluation
within (intra-) and across (inter-) platforms will be performed.
Results
MicroRNA profiling using three platforms
A total of 40 human osteosarcoma xenograft specimens were
employed for this study, which included 10 samples for each
chemotherapeutic treatment (Cisplatin, Doxorubicin, and Ifosfa-
mide) plus 10 non-treated samples. Locked Nucleic Acid (LNA)
miRNA array, beads array, and TaqMan Low Density Array
(TLDA) cards profiled 560, 319, and 664 human miRNAs,
respectively. TLDA shared 508 and 231 miRNAs with LNA array
and beads array, respectively, and LNA array has 221 overlapped
miRNAs with beads array. A total of 213 miRNAs were shared by
three platforms, as illustrated in Figure S1.
Signal quality and background noise comparisons
Figure 1 compares the distributions of the log2 intensity
measures for all the samples tested by the three platforms. The
left panel illustrates the distribution of all miRNAs from three
different platforms while the right panel displays the distribution of
the 213 shared miRNAs. For each plot, we see that within each
platform, the distributions of different profiles (without normali-
zation) show similar patterns. By comparing each pair of plots in
each row, especially (a) versus (b) and (e) versus (f), we find that the
left modes are lower after the non-overlapped miRNAs are
excluded. Meanwhile, the patterns of the distributions maintain
similarity, indicating that a majority of the non-overlapped
miRNAs are weakly expressed.
The signal-to-noise ratio (SNR) is a statistical tool that measures
the quality of the signals that are obtained from the arrays. When
SNR is low, the background noise could dominate the measured
expression signal and thus increase the uncertainty in evaluating
gene expression levels. We computed the SNR for each miRNA in
the LNA and beads arrays by dividing the background-subtracted
signal by the estimated background noise. Results show that the
beads array has an overall higher SNR than the LNA array
(Figure 2). A number of probes have lower intensity than the
background on the LNA array, which causes log (SNR) values to
be negative. The SNR was not computed for TLDA because there
were no estimates for the background noises in qRT-PCR.
Intra-platform reproducibility
To evaluate the intra-platform reproducibility, we calculated
the rank-based Spearman’s correlation coefficients among various
miRNA profiles tested on different samples by the same platform.
A stable platform is expected to produce similar results across
different experiments. In other words, the results from the same
sample using the same platform should be reproducible. The
Pearson correlation coefficient analysis was banned because the
study demonstrated that array profiling data were mostly non-
linear [23,24]. By using the Spearman’s correlation coefficient
measurement to evaluate intra-platform reproducibility, which
adopts the rank information, the different scales used in each
platform may be ignored and log-transformation can be avoided.
From the three box plots on the left in Figure 3, we see that the
beads array has the highest intra-platform reproducibility with a
median Spearman correlation of 0.8544 and a standard deviation
of 0.0475. The first and third quartiles are 0.8189 and 0.8877,
respectively. TLDA has a median coefficient of 0.8118 with a
standard deviation of 0.0745. The median coefficient of the LNA
array is 0.7367, and the standard deviation is 0.0759. The
correlation coefficients are computed based on the profiles of 213
overlapping miRNAs that are undergoing the same treatment.
Our results demonstrate that the intra-platform reproducibility of
all three platforms are acceptable and have no significant
differences.
Inter-platform consistency
The Spearman’s correlation coefficients were also employed to
evaluate the inter-platform reproducibility between any two
platforms. The three box plots on the right in Figure 3 show the
coefficients among the three platforms. Both beads array and
TLDA display relatively good inter-platform reproducibility with
LNA array. The median coefficient between LNA and beads
arrays is 0.4521 with a standard deviation of 0.0537, and the
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improved (0.4872) but with a slightly larger standard deviation of
0.0962. The reproducibility between beads array and TLDA is
much lower, with a median coefficient of 0.1060 and a standard
deviation of 0.0391.
The evaluation of endogenous controls/probes for each
platform
Our models measured the miRNA profiles of 10 xenograft
samples. In order to evaluate the stability of endogenous controls/
probes contained in each array, we employed 30 chemo drug
treated samples and 10 untreated control samples to constitute the
research models. The details will be described in the Material and
Methods.
LNA array includes 12 snoRNAs purposed for normalization.
Table S1 compares their stability by computing coefficients of
variation (CVs) based on the four replicates of 12 snoRNAs on
each array. When processing raw data, if the signal intensity is less
than 2 standard deviations from the background intensity, the
probe will be flagged by the ImaGene 7.0 software. We found a
few probes out of all 12 snoRNAs to be flagged across the 40
samples; however, hsa_SNORD2, hsa_SNORD3, hsa_SNORD6,
hsa_SNORD10, and U6-snRNA-1 have relatively stable CVs
compared to the remaining controls. In particular, hsa_SNORD2
has the smallest CVs and has no flagged probes across the 10
control samples. Because hsa_SNORD3 has a few outstanding
measurements in some samples (data not show), we finally selected
hsa_SNORD2, hsa_SNORD6, hsa_SNORD10, and U6-snRNA-
1 for the further analyses. The expression patterns of these four
controls, as determined by their absolute intensities, are presented
in Figure 4A.
Beads array includes four normalization beads, which harbor
probes that target ubiquitous small nucleolar RNAs (snoRNAs),
useful for intra- and inter-sample normalization, upon successful
Figure 2. Signal-to-noise ratio comparison between beads array and LNA array. Plot (a) shows the density curves of the log signal-to-noise
ratios for different samples tested by beads array, while the results for LNA array are demonstrated in plot (b). A log signal-to-noise ratio close to
‘‘one’’ indicates that the signal after background subtraction is close to the background noise.
doi:10.1371/journal.pone.0017167.g002
Figure 1. Expression distributions of miRNAs being profiled by the three platforms. Plots (a), (c) and (e) demonstrate the density curves of
the expression of all miRNAs being profiled by LNA array, beads array, and TLDA, respectively. Plots (b), (d) and (f) compare the density curves of the
expressions of the overlapped miRNAs from all three platforms. We took a log2 transformation to all intensity measures. For TLDA data, the {DCt
values were used.
doi:10.1371/journal.pone.0017167.g001
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samples. Their relatively close expression patterns, determined by
using the intensity values after background subtraction, are
exhibited in Figure 4B.
A complete miRNA profile requires use of two TLDA cards,
Cards A and B; Card A contains three endogenous controls
(MammU6, RUN44, and RUN48) for relative quantitation, while
B contains six endogenous controls (MammU6, RNU6B, RNU24,
RNU43, RNU44, and RNU48). Figure 4C shows the profiles of
the three endogenous controls common in the two cards
(MammU6, RUN44, and RUN48) presented by Ct values.
To compare the stability of all endogenous controls/probes used
within the three platforms, we again employed CVs by taking the
expression levels into consideration (Figure 5). For the TLDA and
LNA arrays, the CVs were computed based on the replicates of
each control/probe in a single array, while in the beads array, the
CVs were computed based on the intensities after intra-sample
normalization for the four normalization beads from the five pools
for each sample. From Figure 5, we find that the CVs of the four
snoRNAs in LNA array have much larger means and variances
compared to those on the other two platforms. Three endogenous
controls in TLDA have the best performance with the small means
and standard deviations.
Proper normalization methods improve consistency
between the platforms
The low data consistency using inter-platform comparison bans
data integration across the platforms. There are many reasons that
could lead to this concern, such as array design, properties, signal
measurement, et al, but we assume that normalization might be
one adjustable factor, as we previously reported [25]. In order to
improve the inter-platform consistency, we introduced two
additional and popularly used normalization methods [26,27],
quantile and loess, in parallel with using designated probes/beads
for normalization. TLDA data was removed from the normaliza-
tion by quantile and loess since its signals were presented as cycle
threshold (CT), which denotes the number of PCR cycles required
for the fluorescent signal to cross a designated threshold level
above a calculated background, rather than being presented as
intensity values for the probes, as LNA and beads array utilize. We
demonstrated earlier that TLDA included the most stable
endogenous controls, and, considering the suggestion of others
[21,22], we used the results from TLDA as a standard to evaluate
the performance led by different normalization methods when
applied to the analysis of LNA and beads arrays.
In this study, we also utilized sensitivity and specificity, two
statistical measures of the performance of a binary classification, as
test statistics of each platform to measure the inter-platform
reproducibility. Our foremost assumption regarding the use of raw
miRNA data for such a study is that a given miRNA from a single
patient after a single treatment should maintain a consistent trend
of up- or down-regulation across each platform, and an effective
miRNA expression profiling platform should be capable of
assessing the true direction of regulation. Thus, we compared
the sensitivity and specificity of beads array (Figure 6; left panel)
and LNA array (right panel), using the TLDA results as a
Figure 3. Intra- and inter-platform reproducibility comparisons. The first box plot to the left is based on Spearman’s correlation coefficients
between the LNA profiles of any two samples under the same treatment. The second and third plots are for the beads array and TLDA, respectively.
The fourth plot is constructed based on the Spearman’s correlation coefficients between the two profiles obtained by beads array and LNA array
based on the same sample under the same treatment for all 10 samples. The fifth plot shows the results between beads array and TLDA, while the
sixth plot shows the results between LNA array and TLDA.
doi:10.1371/journal.pone.0017167.g003
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fold-change cutoffs (x-axis). As shown in the left plot in the first
row, the specificity is high when normalizing the profiling data of
beads array by the four normalizers; however, the sensitivity is low.
The loess method can improve the sensitivity and lower the
specificity as a trade-off for the beads array data, while quantile
normalization and the scaling method have similar effects on the
beads data. By comparing the results of beads array with that of
LNA array, we see that the consistency of LNA array in predicting
the regulation trends (up- or down-regulated) is better than beads
array, consistent with the results of inter-platform reproducibility
as assessed by correlation coefficients. Additionally, quantile and
loess normalization can improve the consistency of beads array
and LNA array with TLDA, although the choice of optimal cutoff
value could be slightly different.
Discussion
MiRNA continues to attract more and more attention in the
biomedical field due to its important roles in many cellular and
molecular processes [3,4,5,6,7,8,9]; however, unlike DNA, mRNA,
and protein, the genomic methodologies for miRNA discovery and
validation are not well-developed when considering they are
prospective in basic and clinical research. For example, there are
relatively few specific normalization methods currently available for
miRNA profiling analysis [25]. Even though many well-established
methods for mRNA/cDNA and protein have been applied in
miRNA analysis, their performance is still under evaluation,
partially due to a shortage of effective validation methods that can
assess the ‘‘real’’ presence and activity of miRNA. The total number
of known human miRNAs to date is 939, according to the Sanger
database, which is much lower than the number of known human
gene transcripts (,50 k). Any profiling normalization methods
based on normal distribution canbe appliedto this small population
estimation but the accuracy of those methods is questionable [25].
In this study, using a large cohort of samples constituting unique
models exposed to different environments, we evaluated three
representative platforms based on different mechanisms/carriers
that have been applied for miRNA profiling, including LNA array,
beads array, and TLDA. The distribution of intensity measures
from each profile appear as variable patterns, which could be
attributed to differences in signal collection and scales of
measurement. Surprisingly, the SNR of the LNA array was
secondary to the beads array; however, each probe for LNA had
four technical duplicates, potentially overcoming the disadvantage
of a weaker signal to some extent. Each array contained variable
probe types based on the array’s design or capacity, but 213
miRNAs were shared by three platforms. These miRNAs had
similar distribution patterns in each array, indicating that they
could represent each array for further analyses.
Git et al. compared microarray (from Agilent, Exiqon, Ambion,
Invitrogen, and Combimatrix), qRT-PCR, and next generation
sequencing (NGS) technologies for the miRNA profiles of three
cell lines. They found that the actual overlap between the
differentially expressed miRNAs was surprisingly low when
comparing microarray, NGS, and qRT-PCR data [28]. Sato
et al. also evaluated five commercial miRNA microarray platforms
from Agilent, Exiqon, Ambion, Invitrogen, and Toray using two
RNA samples and found the miRNA microarray to have high
intra-platform repeatability and comparability to qRT-PCR but
lower inter-platform concordance [29]. Using the designated
normalization controls/probes for each array, we computed the
intra- and inter-platform reproducibility. Our results demonstrat-
ed that the intra-platform reproducibility of all three platforms is
reasonable, while the beads array is the most consistent. The LNA
array and TLDA had the best inter-platform correlation while the
TLDA and beads arrays were the least correlated. These
observations are in agreement with the above reports [28,29].
Multiple factors could potentially contribute to low inter-
platform consistency, such as data collecting, mining, noise
subtracting, etc. Normalization methods have thus been accepted
to play an important role in data comparison and its integration
across platforms [25,26,28,30]. Specific controls have been
recommended for miRNA normalization because data acquired
from the small total number of miRNAs results in insufficient
statistical power that can be used to adopt established mRNA
profiling normalization methods [25]. The ideal controls should be
consistently stable and highly abundant despite tissue types or
treatments. Additionally, they should have properties similar to
those of miRNAs, including size, biogenesis and stability [25].
Each platform employed herein includes a number of such
controls with the potential to act as normalizers. Our unique
models consisted of 10 untreated xenograft controls; each had
three different chemo drug treatments, which resulted in a total of
40 samples. The beads array included four normalization beads of
synthesized short oligos used to maintain consistency across
samples and treatments. Similarly, the LNA array included 12
snoRNAs, and the TLDA contained three endogenous controls
common to Cards A and B, which contributed to computing the
relative quantity for each miRNA. When examining these
controls, the beads array and TLDA performed better than the
LNA array, which had only four controls that maintained
relatively stable expression patterns across all samples.
We performed normalization for each array using the most stable
controls. By adding two broadly applied normalization methods,
quantile and loess, for comparison, we computed the sensitivity and
specificity for each array. Endogenous controls in TLDA performed
better across treatments, though its relative measures are calculated
by 2{DDCt, which is an unsuitable factor for normalization by the
quantile and loess methods. Therefore, we used the TLDA data as a
reference for evaluating the beads and LNA array because others
have suggested qRT-PCR to be a gold standard for relative
quantitation [22]. Our results indicate that proper normalization
methods can improve the sensitivity and specificity of such
platforms,; these results are in line with previous reports [26,30].
Next generation sequencing (NGS) has been pushing for reform
in the field of genomics [31] and has been projected to replace the
use of microarray in the near future. Its introduction into miRNA
research can be attributed to its ability to read short fragments in a
high throughput pattern [32]. Most researchers, including us, agree
with the prospective of this newly developed technology though it
should beadmitted that the NGSsequencing technologyis stillnot a
fully mature especially when compared to the microarray, which
Figure 4. Comparison of three platforms’ miRNA profiling data. (A) LNA array: The expressions of the four normalization probes in each
LNA array are plotted, which have similar patterns across 10 samples under the four different treatments. (B) Beads array: The expressions of the
four normalization beads in the five pools while testing 40 different samples are compared, which have similar patterns in the five pools across
samples and indicate that these transcripts do not express significant variation between pools and samples. (C) TLDA: The profiles of the three
endogenous controls commonly used by TLDA Cards A and B are demonstrated relatively stable across samples and treatments. Ctrl, Cis, Dox, and Ifo
represent control, and three different chemo drug treatments.
doi:10.1371/journal.pone.0017167.g004
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based on RNA ligation, PCR amplification, and professional
bioinformatic support, challenging its application in quantitative
gene expression analysis due to cost, labor, and time consumption
concerns [28]. Though it will take time for NGS to fully take over
the microarray, its unique and outstanding sequence discovery
capability is making NGS become a combatant to the microarray.
Hopefully, the imminent advent of third generation sequencing
Figure 5. Stability evaluation for endogenous controls/probes from three platforms. The box plots of coefficient of variation (CV) values
for each projected normalizer are calculated by using the measures of the replicates. Ctrl, Cis, Dox, and Ifo represent control, and three different
chemo drug treatments.
doi:10.1371/journal.pone.0017167.g005
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e17167Figure 6. Inter-platform reproducibility measured by sensitivity and specificity. Sensitivities were compared to evaluate the consistency
among the three platforms. The three plots in the first column compare the consistency between beads array and TLDA, the three plots in the second
column compare the consistency between LNA array and TLDA, and the plots in the third column compare the consistency between beads array and
LNA array. The results in the first, second and third rows are based on the profiles normalized using scaling by specific controls/probes, quantile
normalization, and the cyclic loess method, respectively.
doi:10.1371/journal.pone.0017167.g006
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research platform availability for the future.
LNA array, beads array, and TLDA —three miRNA profiling
platforms based on different mechanisms/carriers— exhibit better
intra-platform consistency than inter-consistency, though each
platform has its inherent merits and shortcomings. For example,
LNA is an affordable platform with novel LNA technology and
probe extending capacity but low SNR and unreliable normali-
zation probes. The beads array has better intra-consistency but
interference between short probes has to be considered. Even
though the beads array has extending capacity, more input
templates will reduce enthusiasm for its use. Both the LNA and
beads arrays use a direct labeling process without template
amplification, which eliminates the errors acquired from PCR.
TLDA is an easy-to-use and effective solution for miRNA profiling
but it is costly with limited extending capacity and no replicates are
available at this time. Therefore, TLDA may be better applied to
validation rather than discovery.
We are not advertising any platforms. We have attempted to
evaluate the scientific merit of each applied miRNA profiling
platform and provide useful evidence for our peers when selecting
miRNA analytic strategies. Unfortunately, we could not identify
any of these to be superior to the others due to their low inter-
platform consistency. Thus, users should select a platform based
on their available facilities, budget, interests, and/or loyalties;
although, the selection of proper normalization and validation
methods will clearly be one of the most critical factors in
determining the best miRNA candidates. Therefore, we conclude
that it is important to develop specific normalization methods for
miRNA profiling in order to improve the accuracy of proofing
data and provide the possibility of data integration across
platforms, profound even in the future sequencing era.
Materials and Methods
Sample preparation and assessment of total RNA
concentration, purity and quality
Forty human osterosarcomaxenografts were collected as described
in the previous publication [33]. Frozen xenografts were ground by a
stainless steel mortar and pestle under liquid nitrogen. Total RNA
was isolated from the tissue powder using Trizol Reagent (Invitrogen,
CA, USA) and was quantitated using a NanoDrop spectrophometer
(Thermo Fisher Scientific Inc., MA, USA).
MiRNA expression analysis using LNA array
Total RNA was labeled using the miRCURY LNA microRNA
Array power labeling kit (Exiqon Inc., Denmark). All reagents used
here were from Exiqon unless specifically mentioned. In brief, a
4 ml reaction volume consisting of 0.5 ml CIP buffer, 0.5 ml CIP
enzyme, 1 ml Spike-in controls and 1 mg total RNA was incubated
at 37uC for 30 min followed by 95uC for 5 min. The CIP reaction
products were mixed with 3 ml labeling buffer, 1.5 ml Hy5
fluorescent label, 2 ml labeling enzyme, and 2 ml DMSO and
were placed in the dark at 16uC for 60 min. The total volume of
the labeled samples was adjusted to 200 ml by adding nuclease-free
water, then mixed with an equal volume of 26 hybridization
buffer at 95uC for 2 min and immediately cooled down on ice.
The samples were loaded on the miRCURY LNA microRNA
Array (Exiqon Inc.; based on miRbase 9.2) using a hybridization
SureHyb chamber kit and gasket slide kit (Aglient Technologies,
CA, USA). The slides were then rotated at 56uC for 16 hrs. After
disassembling the chambers, the slides were washed in three steps.
The first step was to immediately soak the slides in pre-warmed 26
salt buffer, containing 0.2% detergent solution, for 2 min. The
second step was to rinse the slides with 16salt buffer for 10 sec
and then wash for 2 min in fresh 16salt buffer. The third step was
to use 0.26 salt buffer to wash the slides for 2 min. Finally, the
slides were quick-dried by centrifuging at 1000 rpm for 2 min.
Scanning was performed by an Axon GenePix Professional 4200A
microarray scanner (Molecular Devices, CA, USA). Finally, the
images were gridded and analyzed using ImaGene 7.0 software
(BioDiscovery Inc., CA, USA).
MiRNA expression analysis using beads array
Five mg (one mg per bead pool) of total RNA per sample in a
40 ml reaction volume were 39-biotinylated using Luminex
FlexmiR MicroRNA Labeling Kit (Luminex Corp., TX, USA),
following manufacturer protocol. Using the Luminex FlexmiR
MicroRNA Human Panel of reagents and xMAP beads, 8 mlo f
biotin-labeled total RNA, or water for the background control,
were added to an equal volume of a single pool of microspheres
(five pools total in the Human Panel targeting 319 miRNA), 14 ml
of hybridization buffer and 20 ml water, mixed and covered to
protect from evaporation and light, and denatured at 95uC for
3 min in a 96-well plate. Biotinylated miRNA were then
hybridized to oligonucleotide-capture probes coupled to the
carboxylated 5-micron polystyrene xMAP beads at 60uC for one
hour. Following hybridization, the beads were washed and filtered,
and 75 ml streptovidin-phycoerythrin:wash buffer (1:300) reporter
were added to the beads and incubated at room temperature on a
plate shaker (600 rpm) for 30 min. Median fluorescence intensity
(MFI) values were then measured using a Luminex 200 machine.
MiRNA expression analysis using TLDA
The global profiling for miRNA expression for 40 samples was
performed using the TaqMan Array Human MicroRNA Panel v2.0
(Applied Biosystems, CA, USA), which includes Cards A and B in a
384-well format. Card A contains 380 TaqMan MicroRNA Assays
enabling the simultaneous quantitation of 377 human miRNAs plus 3
endogenous controls; Card B contains 293 assays for 287 human
miRNAs plus 6 controls, which were experimental procedures
following manufacturer instructions. In brief, total RNA was first
reverse-transcribed with the Multiplex RT pool set (Applied
Biosystems) through a reverse transcription (RT) step using the
High-Capacity cDNA Archive Kit (Applied Biosystems), wherein a
stem-loop RT primer specifically binds to its corresponding miRNA
and initiates its reverse-transcription. The RT mix included 50 nM
s t e m - l o o pR Tp r i m e r s ,1 6 RT buffer, 0.25 mM each of dNTPs,
10 U/ml MultiScribe reverse transcriptase, and 0.25 U/mlR N a s e
inhibitor.The7.5 ml reaction was then incubated for 30 min at 16uC,
30 min at 42uC, 5 min at 85uC ,a n dt h e nh e l da t4 uC. The RT
products were subsequently amplified with sequence-specific primers;
we were using the Applied Biosystems 7900 HT Real-Time PCR
system. Six ml of RT products were added to 444 ml nuclease free
water and mixed with 450 ml TaqMan Universal Master Mix II, No
UNG, then dispensed into the 384 wells by centrifugation. The
reactions were incubated in a 384-well plate at 95uC for 10 min
followed by 40 cycles of 95uC for 15 sec and at 60uCf o r1m i n .T h e
data were collected and processed using the Plate Utility and
Automation Controller software (Applied Biosystems). For each
miRNA, the expression level was determined by 2{DDCt value
calculation formula [34].
Normalization methods
Intra-sample and inter-sample normalization for beads
arrays. As recommended by the FlexmiR MicroRNA Human
Panel Instruction Manual, intra- and inter-sample normalization is
performed to normalize the median fluorescent intensity (MFI)
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perform the intra-sample normalization, we first calculated the net
MFI value for each result by subtracting the MFI values of the
background. Second, we selected Pool 1 as the reference and
computed the normalization factors by dividing the net MFI of all
the normalization microspheres in the reference pool by the net
MFI of the corresponding normalization microspheres from other
pools. Third, we computed an intra-sample normalization factor
for each pool by taking the median of the normalization factors of
all the normalization microspheres across each pool. Lastly, we
multiplied each calculated intra-sample normalization factor by all
of the net MFI results within each associated pool.
After the intra-sample normalization, we performed the inter-
sample normalization. First, we regarded the median net MFI
value for each of the four normalization beads across the five pools
as net MFI of the corresponding normalization microspheres.
Second, we selected non-treated samples as controls and used the
net MFI values to compute the normalization factors by dividing
the net MFI of all of the normalization microspheres in the control
sample by the net MFI of the corresponding normalization
microspheres from treated samples. Third, we computed an inter-
sample normalization factor for each sample by taking the median
of the normalization factors of all the normalization microspheres
across each sample. Lastly, we multiplied each calculated inter-
sample normalization factor by all of the net MFI results within
each associated sample.
Normalizing LNA array data by designated probes. Each
LNA array contains 12 designated probes primarily designed
for normalization purposes. Among them, U6-snRNA-1,
hsa_SNORD2, hsa_SNORD6, and hsa_SNORD10 were chosen
to normalize profiling data based on their proved stability earlier.
For each selected probe, we took the median of the intensity
measures after background subtraction from the four replicates for
each array. Then the same inter-sample normalization algorithm
for the beads arrays was applied to normalize the LNA arrays.
Computing coefficients of variation(CVs). CV value is
calculated by dividing the standard deviation of X by the mean
value of X, then multiplying by 100 when defining X as a vector of
the intensities of the replicates.
Cyclic loess. The cyclic loess method, sometimes known as
the MA scatter plot, was first presented by Dudoit et al [35,36].
Let Y be a profile for a sample under a treatment and X be a
profile for the same sample as a control (without treatment). We
first considered the M=log(Y/X) versus A=(log(Y)+log(X))/2
plot. Second, we fit a loess curve by regressing M on A and denote
the fitted values by ^ M M. Third, we set D=exp ((M- ^ M M)/2) and
justified Y and X by Y’=Y*D and X’=X/D. The R loess
function is used with the default smoothing parameter.
Quantile method. The quantile normalization method can
deal with non-linear compressions by effectively taking the ranks of
the observations into account and has been proposed by several
authors [37,38,39]. It transforms all the replicates onto the same
scale. Quantile normalization is applied to a matrix X of spotted
intensities for all p genes and k replicates. Let xij be the spot
intensity for spot j on array i, x(j) be a vector of jth smallest spot
intensities across arrays, and x(j) be the mean/median of x(j). The
vector (x(j)) for j~1,..., p represents the ‘‘compromise’’
distribution. Let R be the matrix of row ranks associated with
matrix X, then the quantile normalized value for spot j on array i
is x(rij). The quantile normalization method has been implemented
in R package affy and is freely available from the The Comprehensive
R Archive Network servers over the internet.
Computation of sensitivity and specificity. In this study,
the sensitivity measures the proportion of actual positives that are
correctly identified as such while specificity measures the
proportion of negatives that are correctly identified.
Sensitivity(i,j)~TP=(TPzFN)
Specificity(i,j)~TN=(TNzFP)
where TP (True Positive) is the number of up- or down-regulated
miRNAs identified consistently by both the TLDA results and the
platform being evaluated (LNA array or beads array), and TN
(True Negative) is the number of non-differentially expressed
miRNAs according to TLDA results and the platform being
evaluated. FN (False Negative) refers to the number of miRNAs
being classified as non-differentially expressed by the platform
being evaluated while being classified as either up-regulated or
down-regulated by the TLDA results. FP (False Negative) refers to
the number of miRNAs being classified as either up-regulated or
down-regulated by the platform being evaluated while being
classified as non-differentially expressed by the TLDA results.
Supporting Information
Figure S1 Venn diagram illustrating the association of
three miRNA profiling platforms. LNA array, beads array,
and TLDA profiled 560, 319, and 664 human miRNAs,
respectively. TLDA shared 508 and 231 miRNAs with LNA
array and beads array, and LNA array has 221 overlapped
miRNAs with beads array. A total of 213 miRNAs were shared by
three platforms.
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Table S1 Stability evaluation of the designated probes
on the LNA array.
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